Aptamers News and Research

RSS
BBSRC, EPSRC fund £1.5M for synthetic biology projects under EuroSYNBIO Programme

BBSRC, EPSRC fund £1.5M for synthetic biology projects under EuroSYNBIO Programme

NOXXON Pharma completes first-in-human clinical trial with Spiegelmer NOX-A12

NOXXON Pharma completes first-in-human clinical trial with Spiegelmer NOX-A12

Dicerna Pharmaceuticals, Ipsen announce collaboration in DsiRNA research and peptide engineering

Dicerna Pharmaceuticals, Ipsen announce collaboration in DsiRNA research and peptide engineering

Regado Biosciences announces first successful subcutaneous application of an aptamer

Regado Biosciences announces first successful subcutaneous application of an aptamer

New strategy against Botulinum toxin

New strategy against Botulinum toxin

Regado Biosciences announces completion of Series D financing

Regado Biosciences announces completion of Series D financing

Albert Einstein College of Medicine receives SU2C grant for cancer research

Albert Einstein College of Medicine receives SU2C grant for cancer research

NOXXON Pharma achieves important milestone in drug discovery

NOXXON Pharma achieves important milestone in drug discovery

Researchers devise a way to deliver right therapy directly to tumors using aptamers

Researchers devise a way to deliver right therapy directly to tumors using aptamers

NOXXON Pharma commences human dosing in Spiegelmer NOX-A12 clinical trial

NOXXON Pharma commences human dosing in Spiegelmer NOX-A12 clinical trial

NOXXON Pharma announces the successful completion of the first phase I trial of Spiegelmer NOX-E36

NOXXON Pharma announces the successful completion of the first phase I trial of Spiegelmer NOX-E36

Researchers engineer antidotes for blood-thinner aptamers

Researchers engineer antidotes for blood-thinner aptamers

New patent grant for oligonucleotide modulators of blood coagulation factor aptamers

New patent grant for oligonucleotide modulators of blood coagulation factor aptamers

First patient enrolled in Phase 2b RADAR clinical trial

First patient enrolled in Phase 2b RADAR clinical trial

URV’s biosensor can detect typhoid causing bacteria instantly

URV’s biosensor can detect typhoid causing bacteria instantly

Aptamer nanoflares for molecular detection in living cells

Aptamer nanoflares for molecular detection in living cells

Reversible cell-specific drug delivery with aptamer-functionalized liposomes

Reversible cell-specific drug delivery with aptamer-functionalized liposomes

Germany’s BMBF awards NOXXON grant for developing Spiegelmer NOX-A12

Germany’s BMBF awards NOXXON grant for developing Spiegelmer NOX-A12

Regado Biosciences to commence Phase I study of a subcutaneous administration formulation of the REG1 anticoagulation system

Regado Biosciences to commence Phase I study of a subcutaneous administration formulation of the REG1 anticoagulation system

Reversible cell-specific drug delivery with aptamer-functionalized liposomes

Reversible cell-specific drug delivery with aptamer-functionalized liposomes